DMCA

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

by Khalid Bajou , Véronique Masson , Robert D. Gerard , Petra M. Schmitt , Valérie Albert , Michael Praus , Leif R. Lund , Thomas L. Fr , Nils Brunner , Keld Dano , Norbert E. Fusenig , Ulrich Weidle , Geert Carmeliet , David Loskutoff , Desiré Collen , Peter Carmeliet , Jean Michel Foidart , Agnès Noël
Venue:J Cell Biol
Citations:34 - 4 self